FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to compounds of formula (V), a pharmaceutical composition, as well as to application in treatment of disease and/or prevention of diseases and disorders, in which inhibition of DPP-IV is beneficial.
EFFECT: obtaining novel compounds of formula (V), having DPP-IV inhibitor activity.
8 cl, 2 dwg, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LONG-ACTING DPP-IV INHIBITOR CRYSTAL AND ITS SALTS | 2017 |
|
RU2753335C2 |
| PYRAZOLO [3,4-C] PYRIDINES AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2638116C2 |
| PIPERIDINE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2016 |
|
RU2730508C2 |
| PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
| INHIBITOR CONTAINING BICYCLIC DERIVATIVE, METHOD OF PREPARATION AND USE THEREOF | 2020 |
|
RU2820948C2 |
| UREA COMPOUND, A METHOD FOR PRODUCTION THEREOF AND MEDICAL USE THEREOF | 2017 |
|
RU2741596C2 |
| INDAZOLE DERIVATIVE, METHOD FOR PREPARATION AND PHARMACEUTICAL USE THEREOF | 2020 |
|
RU2817737C2 |
| PYRAZOLO[3,4-C]PYRIDINE DERIVATIVES | 2015 |
|
RU2709810C2 |
| TRICYCLIC TRIAZOLIC COMPOUNDS | 2014 |
|
RU2666728C2 |
| REGULATORS OF DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND USE | 2019 |
|
RU2803499C1 |
